We are thrilled to announce that our pioneering efforts in the field of radiopharmaceutical kits for immunotherapy have been recognized with the prestigious NIH TABA (Technology Assessment for Biomedical Applications) award. This accolade underscores our commitment to advancing medical science and underscores our dedication to developing cutting-edge solutions that enhance immunotherapy outcomes. The NIH TABA assessment award serves as a testament to our team's unwavering dedication, innovation, and impact in revolutionizing radiopharmaceutical research and its application in the realm of immunotherapy. We remain steadfast in our mission to shape the future of healthcare through groundbreaking advancements.